文献速递头痛与眩晕癫痫

普瑞巴林(乐瑞卡)的发现与开发:公共资金的作用

Discovery and Development of Pregabalin (Lyrica): The Role of Public Funding.
PubMed 文献 · Neurology · 2021-09-07

本研究追溯普瑞巴林从发现到FDA批准过程中接受的美国联邦公共资金资助。普瑞巴林主要基于西北大学公共资助研究被发现,1990年授权给Parke-Davis,2004年获FDA批准。

要点

  • 普瑞巴林最初发现于西北大学,主要基于公共资助研究。
  • 提示广泛销售药物的开发常同时依赖公共部门和产业界贡献。

研究设计与样本

  • 研究通过识别关键研究、科学家和组织,检索PubMed并利用NIH RePORTER判断联邦资助,对批准前奖项进行相关性评分并转换预算为2020年美元。

主要发现

  • 普瑞巴林主要基于西北大学公共资助研究被发现,1990年授权给Parke-Davis,2004年获FDA批准。
  • 关键术语关联了6438项核心项目奖项,主要涉及药物及靶点(n=5)和机构(n=5),其次为专利列名发明人(n=3)。

临床怎么用

  • 提示临床医生了解广泛使用药物(如普瑞巴林)的研发历程中公共资金的重要作用。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND OBJECTIVES: Pregabalin (Lyrica), a widely used drug that has generated billions in revenue as a treatment for diabetic neuropathy and other conditions, was originally discovered in an academic medical center, largely supported by public funding. We aimed to define the extent of direct federal public funding that contributed to various stages of pregabalin's development prior to US Food and Drug Administration (FDA) approval. METHODS: We identified key research, scientists, and organizations involved in the development of pregabalin from its discovery through FDA approval. Using key terms (e.g., its indications and mechanism of action), we searched PubMed for relevant publications and determined whether each publication was based on federal public funding using the NIH RePORTER. For each award prior to the drug's FDA approval, we scored its potential relatedness to pregabalin's development based on its title, investigator, and organization, and then examined descriptions of the most relevant awards to aid in defining these relationships. The budgets for all related awards were converted to 2020 dollars. RESULTS: Pregabalin was discovered largely on the basis of publicly funded research at Northwestern University; in 1990, it was licensed to Parke-Davis, which further developed it through its FDA approval in 2004. Most key terms were related to the drug and drug target (n = 5) and organizations involved (n = 5), followed by patent-listed inventors (n = 3). These key terms linked 6,438 core project awards and we identified 37 NIH awards related to pregabalin's development: 9 awards through 1990 ($3.3 million) and 28 from 1991 through 2004 ($10.5 million). CONCLUSION: Like that of many other widely sold medications, the development of pregabalin relied on public sector as well as industry contributions to its discovery, with relevant NIH awards totaling $13.8 million during its preapproval development.

来源:Neurology,查看原文。版权归原作者所有。

引用

  1. Barenie R, Darrow J, Avorn J, et al. Discovery and Development of Pregabalin (Lyrica): The Role of Public Funding. Neurology. 2021. PMID: 34493615. doi:10.1212/WNL.0000000000012730

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。